Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer (Q78881220)
Jump to navigation
Jump to search
scientific article published on 01 February 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer |
scientific article published on 01 February 2003 |
Statements
Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer (English)
P Kerbrat
V Dieras
N Pavlidis
J Wanders
P Fumoleau
EORTC Early Clinical Studies Group/New Drug Development Office
1 February 2003